Profile | GDS5420 / 228565_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 227.96 | 54 |
GSM1296119 | B_lesional_pre-dose | 232.14 | 54 |
GSM1296076 | C_lesional_pre-dose | 219.91 | 55 |
GSM1296092 | D_lesional_pre-dose | 289.53 | 60 |
GSM1296103 | E_lesional_pre-dose | 289.23 | 59 |
GSM1296078 | F_lesional_pre-dose | 247.73 | 58 |
GSM1296107 | G_lesional_pre-dose | 167.02 | 48 |
GSM1296109 | H_lesional_pre-dose | 183.33 | 50 |
GSM1296080 | I_lesional_pre-dose | 396.48 | 64 |
GSM1296090 | J_lesional_pre-dose | 250.55 | 57 |
GSM1296074 | K_lesional_pre-dose | 242.48 | 58 |
GSM1296111 | L_lesional_pre-dose | 276.07 | 57 |
GSM1296099 | M_lesional_pre-dose | 277.95 | 57 |
GSM1296086 | O_lesional_pre-dose | 264.57 | 58 |
GSM1296117 | P_lesional_pre-dose | 230.81 | 54 |
GSM1296113 | Q_lesional_pre-dose | 240.34 | 54 |
GSM1296096 | R_lesional_pre-dose | 337.29 | 61 |
GSM1296105 | S_lesional_pre-dose | 315.38 | 59 |
GSM1296098 | T_lesional_pre-dose | 180.24 | 50 |
GSM1296101 | U_lesional_pre-dose | 214.23 | 53 |
GSM1296121 | V_lesional_pre-dose | 248.53 | 56 |
GSM1296088 | W_lesional_pre-dose | 220.74 | 55 |
GSM1296082 | X_lesional_pre-dose | 184.78 | 53 |
GSM1296115 | Y_lesional_pre-dose | 249.35 | 56 |
GSM1296084 | Z_lesional_pre-dose | 265.82 | 57 |
GSM1296072 | B_lesional_day8 | 312.32 | 59 |
GSM1296069 | L_lesional_day8 | 226.98 | 53 |
GSM1296071 | P_lesional_day8 | 250.64 | 54 |
GSM1296070 | Y_lesional_day8 | 269.22 | 56 |
GSM1296073 | V_lesional_day8 | 209.47 | 54 |
GSM1296034 | A_lesional_day15 | 396.43 | 63 |
GSM1296041 | G_lesional_day15 | 246.32 | 56 |
GSM1296035 | R_lesional_day15 | 337.19 | 61 |
GSM1296038 | U_lesional_day15 | 297.5 | 59 |
GSM1296047 | B_lesional_day15 | 323.22 | 60 |
GSM1296039 | E_lesional_day15 | 181.71 | 51 |
GSM1296042 | H_lesional_day15 | 187.86 | 50 |
GSM1296043 | L_lesional_day15 | 297.44 | 58 |
GSM1296037 | M_lesional_day15 | 362.45 | 62 |
GSM1296046 | P_lesional_day15 | 379.69 | 62 |
GSM1296044 | Q_lesional_day15 | 285.29 | 57 |
GSM1296045 | Y_lesional_day15 | 293.88 | 57 |
GSM1296025 | C_lesional_day15 | 444.04 | 66 |
GSM1296033 | D_lesional_day15 | 411.41 | 64 |
GSM1296027 | I_lesional_day15 | 480.51 | 67 |
GSM1296032 | J_lesional_day15 | 408.59 | 64 |
GSM1296024 | K_lesional_day15 | 416.07 | 65 |
GSM1296031 | W_lesional_day15 | 305.97 | 59 |
GSM1296028 | X_lesional_day15 | 365.01 | 62 |
GSM1296029 | Z_lesional_day15 | 298.61 | 59 |
GSM1296026 | F_lesional_day15 | 210.86 | 54 |
GSM1296030 | O_lesional_day15 | 393.31 | 64 |
GSM1296040 | S_lesional_day15 | 348.09 | 61 |
GSM1296036 | T_lesional_day15 | 266.67 | 56 |
GSM1296048 | V_lesional_day15 | 200.41 | 52 |
GSM1296059 | A_lesional_day43 | 257.49 | 57 |
GSM1296066 | G_lesional_day43 | 216.79 | 53 |
GSM1296060 | R_lesional_day43 | 329.25 | 60 |
GSM1296063 | U_lesional_day43 | 242.02 | 56 |
GSM1296064 | E_lesional_day43 | 229.33 | 55 |
GSM1296067 | H_lesional_day43 | 268.21 | 56 |
GSM1296062 | M_lesional_day43 | 504.52 | 67 |
GSM1296068 | Q_lesional_day43 | 249.56 | 54 |
GSM1296050 | C_lesional_day43 | 439.94 | 66 |
GSM1296057 | D_lesional_day43 | 270.08 | 57 |
GSM1296052 | I_lesional_day43 | 476.04 | 67 |
GSM1296054 | J_lesional_day43 | 392.15 | 63 |
GSM1296049 | K_lesional_day43 | 416.71 | 65 |
GSM1296055 | W_lesional_day43 | 124.32 | 44 |
GSM1296053 | X_lesional_day43 | 397.42 | 63 |
GSM1296058 | Z_lesional_day43 | 219.28 | 54 |
GSM1296051 | F_lesional_day43 | 234.26 | 56 |
GSM1296056 | O_lesional_day43 | 189.81 | 53 |
GSM1296065 | S_lesional_day43 | 250.61 | 56 |
GSM1296061 | T_lesional_day43 | 158.45 | 48 |
GSM1296095 | A_non-lesional_pre-dose | 274.12 | 58 |
GSM1296120 | B_non-lesional_pre-dose | 287.9 | 58 |
GSM1296077 | C_non-lesional_pre-dose | 459.72 | 66 |
GSM1296093 | D_non-lesional_pre-dose | 403.84 | 63 |
GSM1296104 | E_non-lesional_pre-dose | 168.22 | 49 |
GSM1296079 | F_non-lesional_pre-dose | 577.14 | 70 |
GSM1296108 | G_non-lesional_pre-dose | 252.83 | 56 |
GSM1296110 | H_non-lesional_pre-dose | 447.99 | 65 |
GSM1296081 | I_non-lesional_pre-dose | 611.72 | 71 |
GSM1296091 | J_non-lesional_pre-dose | 435.05 | 66 |
GSM1296075 | K_non-lesional_pre-dose | 296.07 | 60 |
GSM1296112 | L_non-lesional_pre-dose | 446.86 | 65 |
GSM1296100 | M_non-lesional_pre-dose | 278.16 | 57 |
GSM1296087 | O_non-lesional_pre-dose | 348.17 | 63 |
GSM1296118 | P_non-lesional_pre-dose | 475.65 | 66 |
GSM1296114 | Q_non-lesional_pre-dose | 287.31 | 57 |
GSM1296097 | R_non-lesional_pre-dose | 528.32 | 69 |
GSM1296106 | S_non-lesional_pre-dose | 350.65 | 61 |
GSM1296102 | U_non-lesional_pre-dose | 359.6 | 61 |
GSM1296122 | V_non-lesional_pre-dose | 194.12 | 51 |
GSM1296089 | W_non-lesional_pre-dose | 209.88 | 52 |
GSM1296083 | X_non-lesional_pre-dose | 496.69 | 67 |
GSM1296116 | Y_non-lesional_pre-dose | 396.22 | 63 |
GSM1296085 | Z_non-lesional_pre-dose | 335.12 | 61 |